Slows progression,better than nothing I suppose.
Great news, 4 more years of Joe Biden.
Pray that it works safely.
bookmark
Just heard avg cost 4 Gs to do what its is marketed to do
Bye-Done’s picture on the label.
Since the FDA approves drugs that have little more than placebo effect we’ll have to wait and see. FDA approval means nothing any more. Most go work for Pharma after they retire from the US Govt. Sort of like the DoD.
At perhaps $50k a year, it won’t work for most people.
Another monoclonal antibody treatment, in this case, an antibody against amyloid beta.
This is excellent news, and should hopefully work. This is the same general treatment (monoclonal antibody treatment) that regeneron and bamlanivimab are for CoVI-2.
As these are targeted treatments, they will be far more efficacious at curing disease than non-targeted off label medications that may show a low level of efficacy. This is the current state of the art of medicine — and I am glad to see multiple applications of it.
But will I remember to take it?
I see nothing in the Constitution wherein the government is given any say over what I or anyone else put in my body.
The FDA should be merely a quality control organization, if even that.
Wonder if BiteMe is on it...
The FDA still has "emergency use only" classification for the covid vax. Why?
“The approved drug, aducanumab”
Great news but lousy name.
---------------------------------------------------------------------------------------------
.
The FDA Has Approved A New Alzheimer's Drug — Here's Why That's Controversial
"But two large studies offered conflicting evidence about whether the treatment slows declines in memory and thinking. A panel of expert advisers to the FDA recommended in November that the agency not approve the drug.
As a condition of approval, the FDA is requiring Biogen, the drug's maker, to conduct another clinical study to confirm that the reduction of amyloid plaques results in clinical improvement for patients. If the subsequent study doesn't show a clinical improvement, the agency could move to withdraw the approval." https://www.npr.org/2021/06/07/1003964235/fda-approves-controversial-alzheimers-drug-aducanumab
---------------------------------------------------------------------------------------
"The prescribing information includes another warning about hypersensitivity reactions, including angioedema and urticaria. The most common side effects associated with Aduhelm involved ARIA, headache, fall, diarrhea and confusion/delirium/altered mental status/disorientation."
Wait until Vicineum is approved.
It cures bladder cancer.
New York Times
The Food and Drug Administration on Monday approved the first new medication for Alzheimer’s disease in nearly two decades, a contentious decision, made despite opposition from the agency’s independent advisory committee and some Alzheimer’s experts who said there was not enough evidence that the drug can help patients.
Recognizing that clinical trials of the drug had provided incomplete evidence to demonstrate effectiveness, the F.D.A. granted approval on the condition that the manufacturer, Biogen, conduct a new clinical trial.
During the several years it could take for that trial to be concluded, the drug will be available to patients, the agency said. If the post-market study, called a Phase 4 trial, fails to show the drug is effective, the F.D.A. can — but is not required to — rescind its approval.
My #!&÷[=$<÷&##& Brother In Law helped my lovely Sister kill herself in the face of Alzheimers 2 years ago.
I will never forgive him.
Quick! Send Joe a script!
Is Plugs going to plug it?
“Some days, I can’t even remember how to get out of the basement...”